Cargando…
Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9
Orosomucoid 1 (ORM1) has been shown to be upregulated in the serum of breast cancer patients; however, the expression and function of ORM1 in breast cancer remains unknown. We measured the expression of ORM1 in breast cancer tissues and cell lines using qRT-PCR. A colony formation assay was done to...
Autores principales: | Qiong, Luo, Yin, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806942/ https://www.ncbi.nlm.nih.gov/pubmed/34654351 http://dx.doi.org/10.1080/21655979.2021.1987067 |
Ejemplares similares
-
Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017) -
Orosomucoid-1 Expression in Ameloblastoma Variants
por: García-Muñoz, Alejandro, et al.
Publicado: (2016) -
Orosomucoid in liver diseases
por: Elpek, Gulsum Ozlem
Publicado: (2021) -
Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes
por: Qin, Xian-Yang, et al.
Publicado: (2017) -
Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas
por: Fang, Tao, et al.
Publicado: (2015)